Table I.
Clinical characteristics of 40 HCC patients and 6 patients with metastatic liver cancer.
| Patient | Age | Gender | Cancer type | Virus |
|---|---|---|---|---|
| L18 | 70 | M | HCC | HBV |
| L23 | 57 | M | HCC | HBV |
| L34 | 57 | M | HCC | HBV |
| L64 | 48 | F | HCC | HBV |
| L76 | 70 | F | HCC | HBV |
| L84 | 76 | F | HCC | HBV |
| L85 | 51 | M | HCC | HBV |
| L87 | 46 | M | HCC | HBV |
| L116 | 68 | M | HCC | HBV |
| L127 | 40 | M | HCC | HBV |
| L144 | 78 | M | HCC | HBV |
| L154 | 66 | F | HCC | HBV |
| L42 | 66 | M | HCC | HCV |
| L50 | 55 | F | HCC | HCV |
| L63 | 68 | M | HCC | HCV |
| L71 | 75 | M | HCC | HCV |
| L72 | 53 | M | HCC | HCV |
| L77 | 73 | M | HCC | HCV |
| L119 | 63 | F | HCC | HCV |
| L120 | 71 | F | HCC | HCV |
| L124 | 43 | F | HCC | HCV |
| L130 | 63 | M | HCC | HCV |
| L132 | 67 | M | HCC | HCV |
| L155 | 77 | M | HCC | HCV |
| L57 | 58 | M | HCC | - |
| L58 | 73 | M | HCC | - |
| L73 | 85 | M | HCC | - |
| L88 | 72 | M | HCC | - |
| L90 | 65 | M | HCC | - |
| L97 | 80 | M | HCC | - |
| L98 | 75 | M | HCC | - |
| L100 | 77 | M | HCC | - |
| L102 | 69 | M | HCC | - |
| L104 | 64 | F | HCC | - |
| L112 | 78 | M | HCC | - |
| L117 | 47 | M | HCC | - |
| L131 | 76 | M | HCC | - |
| L139 | 73 | M | HCC | - |
| L160 | 56 | M | HCC | - |
| L165 | 50 | F | HCC | - |
| C62 | 56 | M | Metastatic liver cancer | |
| C81 | 70 | M | Metastatic liver cancer | |
| C114 | 54 | M | Metastatic liver cancer | |
| C126 | 59 | M | Metastatic liver cancer | |
| C132 | 65 | F | Metastatic liver cancer | |
| C145 | 76 | M | Metastatic liver cancer |
HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus.